The MedInSynC® philosophy has four strategic components:
The MedInSynC® process has been designed as a way to industrialise our best practices of innovating with our clients' needs at the core. Combined with MedLab® and Med³® (the Mediolanum Asset Management Limited proprietary investment management process), we have an innovation network at MIL that powers our new product delivery.
The MedInSynC® philosophy has four strategic components:
Investment solutions must be saleable and relevant. Based on needs of existing and target clients. Complementary with existing product set. Explainable to clients.
By partnering with the best asset managers in the world we get the best ideas and can implement a “best of the best” suite of products. Cultural diversity enhances the scope and quality of ideas. Ireland is a cluster for technology & investment management innovation.
Products need to be optimal from an investment perspective not just meeting the perceived needs of clients. Closely aligned with our investment teams.
The fund promoter partners not only manage the products, but are responsible for inputting into the products design.